NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Alan Ashworth

The Development of First Time in Human (FTIH), Orally Bioavailable, Small Molecule Tankyrase Inhibitors for the Treatment of Cancer

Colorectum

Marc Brisson

Study and control of human papillomavirus related diseases (CANADA RESEARCH CHAIRHOLDER)

Cervix uteri Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Oesophagus Colorectum Nasopharynx Kidney, renal pelvis and ureter Trachea, bronchus and lung

Meir Stampfer

Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study

Colorectum Breast

Naveenta Kumar

The role of LLT1 in the liver and in hepatocellular carcinoma.

Liver and intrahepatic bile ducts

Mary Anne Rossing

Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer

Ovary

Pathology

Sean Mccurdy

A novel use of E2f and Cdk inhibitors to prevent RB1-null tumors in genetically engineered models of retinoblastoma and other cancers

Brain, nervous system

Pediatric oncology or childhood cancer

Melissa L Bondy

Risk Prediction for ER Negative Breast Cancer Recurrence

Breast

Murray Stewart

Structural cell biology

Prostate

Cory Abate-Shen

Preclinical Analyses of Advanced Prostate Cancer in Genetically-Engineered Mice

Prostate

Pathology